1. Home
  2. VSTM vs LFVN Comparison

VSTM vs LFVN Comparison

Compare VSTM & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • LFVN
  • Stock Information
  • Founded
  • VSTM 2010
  • LFVN N/A
  • Country
  • VSTM United States
  • LFVN United States
  • Employees
  • VSTM N/A
  • LFVN N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • LFVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSTM Health Care
  • LFVN Health Care
  • Exchange
  • VSTM Nasdaq
  • LFVN Nasdaq
  • Market Cap
  • VSTM 425.9M
  • LFVN 165.9M
  • IPO Year
  • VSTM 2012
  • LFVN N/A
  • Fundamental
  • Price
  • VSTM $4.85
  • LFVN $13.40
  • Analyst Decision
  • VSTM Strong Buy
  • LFVN Strong Buy
  • Analyst Count
  • VSTM 9
  • LFVN 2
  • Target Price
  • VSTM $12.63
  • LFVN $30.50
  • AVG Volume (30 Days)
  • VSTM 2.4M
  • LFVN 166.6K
  • Earning Date
  • VSTM 08-07-2025
  • LFVN 08-27-2025
  • Dividend Yield
  • VSTM N/A
  • LFVN 1.19%
  • EPS Growth
  • VSTM N/A
  • LFVN 152.87
  • EPS
  • VSTM N/A
  • LFVN 0.70
  • Revenue
  • VSTM $10,000,000.00
  • LFVN $222,347,000.00
  • Revenue This Year
  • VSTM $129.06
  • LFVN $17.36
  • Revenue Next Year
  • VSTM $306.32
  • LFVN $9.60
  • P/E Ratio
  • VSTM N/A
  • LFVN $19.11
  • Revenue Growth
  • VSTM N/A
  • LFVN 8.22
  • 52 Week Low
  • VSTM $2.10
  • LFVN $5.22
  • 52 Week High
  • VSTM $9.10
  • LFVN $27.38
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 40.44
  • LFVN 59.08
  • Support Level
  • VSTM $4.01
  • LFVN $12.08
  • Resistance Level
  • VSTM $6.62
  • LFVN $12.90
  • Average True Range (ATR)
  • VSTM 0.34
  • LFVN 0.56
  • MACD
  • VSTM -0.03
  • LFVN 0.11
  • Stochastic Oscillator
  • VSTM 42.00
  • LFVN 78.52

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Share on Social Networks: